ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

TYRA Tyra Biosciences Inc

18.30
-0.20 (-1.08%)
Last Updated: 13:05:11
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Tyra Biosciences Inc TYRA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.20 -1.08% 18.30 13:05:11
Open Price Low Price High Price Close Price Previous Close
18.80 16.88 19.39 18.50
more quote information »

Recent News

Date Time Source Heading
5/09/202415:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/09/202415:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
5/09/202415:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/09/202415:08EDGAR2Form 8-K - Current report
5/09/202415:05PRNUSTyra Biosciences Reports First Quarter 2024 Financial..
5/07/202415:34EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
5/07/202415:29EDGAR2Form 8-K - Current report
5/07/202415:05PRNUSTyra Biosciences Announces Appointments of Susan Moran,..
3/19/202415:05PRNUSTyra Biosciences Reports Fourth Quarter and Full Year 2023..
3/08/202416:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202417:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202415:05PRNUSTyra Biosciences to Present at Upcoming Investor Conferences
2/14/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202415:36EDGAR2Form D - Notice of Exempt Offering of Securities
2/12/202415:46EDGAR2Form 144 - Report of proposed sale of securities
2/09/202418:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/07/202415:05PRNUSTyra Biosciences to Present at Oppenheimer's 34th Annual..
2/06/202419:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/06/202415:56EDGAR2Form 144 - Report of proposed sale of securities
2/05/202405:05EDGAR2Form 8-K - Current report
2/02/202416:04EDGAR2Form 144 - Report of proposed sale of securities
2/02/202407:00PRNUSTyra Biosciences, Inc. Announces $200 Million Private..
2/01/202416:30PRNUSTyra Biosciences Receives FDA Rare Pediatric Disease..
2/01/202416:24EDGAR2Form 8-K - Current report
12/22/202308:00EDGAR2Form 8-K - Current report
12/22/202308:00PRNUSTyra Biosciences Doses First Patient with TYRA-200 and..
11/08/202315:05PRNUSTyra Biosciences to Participate in 2023 Jefferies London..
11/07/202315:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202315:07EDGAR2Form 8-K - Current report
11/07/202315:05PRNUSTyra Biosciences Reports Third Quarter 2023 Financial..
10/26/202315:50EDGAR2Form 8-K - Current report
9/21/202307:00PRNUSTyra Biosciences Announces Oral Presentations on TYRA-300..
9/19/202318:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/12/202315:05PRNUSTyra Biosciences to Participate at 2023 Cantor Global..
8/10/202315:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202315:21EDGAR2Form 8-K - Current report
8/10/202315:05PRNUSTyra Biosciences Reports Second Quarter 2023 Financial..
8/01/202316:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/01/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/01/202307:54DJNTyra Biosciences Gets FDA Orphan Designation for TYRA-300 in..
8/01/202307:00PRNUSTyra Biosciences Announces FDA Orphan Drug Designation for..
7/21/202319:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/17/202318:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/12/202317:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/03/202316:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/28/202319:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/25/202307:00PRNUSTyra Biosciences to Participate in Upcoming Investor..